์ฝ๋ ๋ฐฉ๋ฒ: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
Capstone Therapeutics was a biotechnology company committed to developing novel therapeutic peptides aimed at helping patients with under-served medical conditions.
About Capstone Holding Corp. The Company's primary business activities presently include the operations of TotalStone, LLC, a construction materials company.
ALSIP, IL/ ACCESS Newswire/ March 5, 2025/ Capstone Holding Corp., a building products distribution company that has successfully grown its business organically and through well-timed acquisitions ...
ALSIP, IL / ACCESS Newswire / June 17, 2025 / Capstone Holding Corp. (NASDAQ:CAPS) today announced that its Instone subsidiary secured a $1 million order for Pangaeaยฎ Natural Stone as part of a ...
NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Capstone Holding Corp. (NASDAQ:CAPS), a national building products distribution platform, today announced the formation of a dedicated ...
Capstone Holding Corp. (NASDAQ:CAPS), currently trading at $1.29 per share and showing significant volatility according to InvestingPro, announced Thursday that it has amended the terms of its ...
Deal delivered at target 4-6ร EBITDA range; strengthens platform with premium brands in high-growth construction market NEW YORK CITY, NY / ACCESS Newswire / August 25, 2025 / Capstone Holding Corp. ( ...
ALSIP, IL - Capstone Holding Corp. (NASDAQ:CAPS), a distributor of building products, has reiterated its financial goals for 2025, aiming to reach a $100 million revenue run-rate and $10 million ...
Effective November 16, 2023, the Company reached agreement to revise its accounting treatment for Capstone Beta, LLC's note investment in Diamond Products Holdings, LLC based on the following ...
About Capstone Holding Corp. Capstone Holding Corp. (NASDAQ: CAPS) is a diversified platform of building products businesses focused on distribution, brand ownership, and acquisition.
Our AI model demonstrates 13% historical accuracy for CAPS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
